{"id":383281,"date":"2020-11-17T12:13:20","date_gmt":"2020-11-17T17:13:20","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=383281"},"modified":"2020-11-17T12:13:20","modified_gmt":"2020-11-17T17:13:20","slug":"moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\/","title":{"rendered":"Moore Kuehn Encourages CGIX, AKER, TGC and DNKN Investors to Contact Law Firm"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">NEW YORK<\/span>, <span class=\"xn-chron\">Nov. 17, 2020<\/span> \/PRNewswire\/ &#8212;\u00a0Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown <span class=\"xn-location\">New York City<\/span>, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders.\u00a0Moore Kuehn may ultimately seek increased consideration, additional disclosures, or other relief and benefits on behalf of the\u00a0shareholders of these companies:<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/698123\/Moore_Kuehn_Logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/698123\/Moore_Kuehn_Logo.jpg\" title=\"(PRNewsfoto\/Moore Kuehn, PLLC)\" alt=\"(PRNewsfoto\/Moore Kuehn, PLLC)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<ul type=\"disc\">\n<li>\n          <b><br \/>\n            <u>Cancer Genetics, Inc. (<\/u><br \/>\n          <\/b><br \/>\n          <b><br \/>\n            <u>NASDAQ: CGIX)<\/u><br \/>\n          <\/b>\n        <\/li>\n<\/ul>\n<p>A registration statement was recently filed with the SEC regarding StemoniX&#8217;s acquisition of Cancer Genetics.\u00a0 Under the proposed transaction, Cancer Genetics shareholders will control 22% of the combined company.\u00a0 The investigation concerns whether Cancer Genetics&#8217;s board oversaw an unfair process and ultimately agreed to an inadequate price. <\/p>\n<ul type=\"disc\">\n<li>\n          <b><br \/>\n            <u>Akers Biosciences, Inc. (<\/u><br \/>\n          <\/b><br \/>\n          <b><br \/>\n            <u>NASDAQ: AKER<\/u><br \/>\n          <\/b><br \/>\n          <b><br \/>\n            <u>) <\/u><br \/>\n          <\/b>\n        <\/li>\n<\/ul>\n<p>Akers Biosciences has agreed to be acquired by MYMD Pharmaceuticals.\u00a0\u00a0Under the proposed transaction, Akers shareholders will own approximately 20% of the combined company.<\/p>\n<ul type=\"disc\">\n<li>\n          <b><br \/>\n            <u>Tengasco, Inc. (<\/u><br \/>\n          <\/b><br \/>\n          <b><br \/>\n            <u>NYSE: TGC)<\/u><br \/>\n          <\/b>\n        <\/li>\n<\/ul>\n<p>Tengasco has agreed to merge with Riley Exploration &#8211; Permian, LLC.\u00a0 Under the proposed transaction,\u00a0current TGC stockholders will own the remaining 5% of the combined company.<\/p>\n<ul type=\"disc\">\n<li>\n          <b><br \/>\n            <u>Dunkin&#8217; Brands Group, Inc. <\/u><br \/>\n          <\/b><br \/>\n          <b><br \/>\n            <u>(NASDAQ: DNKN)<\/u><br \/>\n          <\/b>\n        <\/li>\n<\/ul>\n<p>A tender offer expiring on <span class=\"xn-chron\">December 15<\/span><sup>th<\/sup> was commenced by Inspire Brands to acquire Dunkin&#8217; Brands Group for <span class=\"xn-money\">$106.05<\/span> per share.\u00a0 The solicitation statements filed with the SEC in support of the acquisition may omit material information regarding the financial metrics and analyses used to evaluate the merger.\u00a0 <\/p>\n<p>Moore Kuehn is investigating whether\u00a0the Boards of the above companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process.\u00a0 <\/p>\n<p>Moore Kuehn encourages shareholders who would like to discuss their rights\u00a0to contact <span class=\"xn-person\">Justin Kuehn, Esq.<\/span> by email at <a target=\"_blank\" href=\"mailto:jkuehn@moorekuehn.com\" rel=\"nofollow noopener noreferrer\">jkuehn@moorekuehn.com<\/a> or telephone at (212) 709-8245.\u00a0 <b>The consultation and case\u00a0are free with no obligation to you.\u00a0 <\/b>\u00a0\u00a0<i>Shareholders should contact the firm immediately as there may be limited time to enforce your rights.<\/i><b>\u00a0<\/b>\u00a0<\/p>\n<p>Moore Kuehn is a 5-star <span class=\"xn-location\">New York City<\/span>-based law firm with attorneys representing investors and consumers in class action litigation involving securities law violations, financial fraud, breaches of fiduciary duties, and other claims.\u00a0 For additional information about Moore Kuehn, please go to <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2984792-1&amp;h=2381830311&amp;u=http%3A%2F%2Fwww.moorekuehn.com%2Fpractice%2Fnew-york-securities-litigation%2F&amp;a=http%3A%2F%2Fwww.moorekuehn.com%2Fpractice%2Fnew-york-securities-litigation%2F\" rel=\"nofollow noopener noreferrer\">http:\/\/www.moorekuehn.com\/practice\/new-york-securities-litigation\/<\/a>.<\/p>\n<p>Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>Contacts:<br \/>Moore Kuehn, PLLC<br \/><span class=\"xn-person\">Justin Kuehn, Esq.<\/span><br \/>30 Wall Street, 8<sup>th<\/sup> Floor<br \/><span class=\"xn-location\">New York, New York<\/span> 10005<br \/><a target=\"_blank\" href=\"mailto:jkuehn@moorekuehn.com\" rel=\"nofollow noopener noreferrer\">jkuehn@moorekuehn.com<\/a><br \/>(212) 709-8245<\/p>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY94832&amp;sd=2020-11-17\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm-301175116.html\">http:\/\/www.prnewswire.com\/news-releases\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm-301175116.html<\/a><\/p>\n<p>SOURCE  Moore Kuehn, PLLC<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY94832&amp;Transmission_Id=202011171210PR_NEWS_USPR_____NY94832&amp;DateId=20201117\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK, Nov. 17, 2020 \/PRNewswire\/ &#8212;\u00a0Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders.\u00a0Moore Kuehn may ultimately seek increased consideration, additional disclosures, or other relief and benefits on behalf of the\u00a0shareholders of these companies: Cancer Genetics, Inc. ( NASDAQ: CGIX) A registration statement was recently filed with the SEC regarding StemoniX&#8217;s acquisition of Cancer Genetics.\u00a0 Under the proposed transaction, Cancer Genetics shareholders will control 22% of the combined company.\u00a0 The investigation concerns whether Cancer Genetics&#8217;s board oversaw an unfair process and ultimately agreed to an inadequate price. Akers Biosciences, Inc. ( NASDAQ: AKER ) Akers &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Moore Kuehn Encourages CGIX, AKER, TGC and DNKN Investors to Contact Law Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-383281","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Moore Kuehn Encourages CGIX, AKER, TGC and DNKN Investors to Contact Law Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Moore Kuehn Encourages CGIX, AKER, TGC and DNKN Investors to Contact Law Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK, Nov. 17, 2020 \/PRNewswire\/ &#8212;\u00a0Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders.\u00a0Moore Kuehn may ultimately seek increased consideration, additional disclosures, or other relief and benefits on behalf of the\u00a0shareholders of these companies: Cancer Genetics, Inc. ( NASDAQ: CGIX) A registration statement was recently filed with the SEC regarding StemoniX&#8217;s acquisition of Cancer Genetics.\u00a0 Under the proposed transaction, Cancer Genetics shareholders will control 22% of the combined company.\u00a0 The investigation concerns whether Cancer Genetics&#8217;s board oversaw an unfair process and ultimately agreed to an inadequate price. Akers Biosciences, Inc. ( NASDAQ: AKER ) Akers &hellip; Continue reading &quot;Moore Kuehn Encourages CGIX, AKER, TGC and DNKN Investors to Contact Law Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-17T17:13:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/698123\/Moore_Kuehn_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Moore Kuehn Encourages CGIX, AKER, TGC and DNKN Investors to Contact Law Firm\",\"datePublished\":\"2020-11-17T17:13:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\\\/\"},\"wordCount\":407,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/698123\\\/Moore_Kuehn_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\\\/\",\"name\":\"Moore Kuehn Encourages CGIX, AKER, TGC and DNKN Investors to Contact Law Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/698123\\\/Moore_Kuehn_Logo.jpg\",\"datePublished\":\"2020-11-17T17:13:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/698123\\\/Moore_Kuehn_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/698123\\\/Moore_Kuehn_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Moore Kuehn Encourages CGIX, AKER, TGC and DNKN Investors to Contact Law Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Moore Kuehn Encourages CGIX, AKER, TGC and DNKN Investors to Contact Law Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\/","og_locale":"en_US","og_type":"article","og_title":"Moore Kuehn Encourages CGIX, AKER, TGC and DNKN Investors to Contact Law Firm - Market Newsdesk","og_description":"PR Newswire NEW YORK, Nov. 17, 2020 \/PRNewswire\/ &#8212;\u00a0Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders.\u00a0Moore Kuehn may ultimately seek increased consideration, additional disclosures, or other relief and benefits on behalf of the\u00a0shareholders of these companies: Cancer Genetics, Inc. ( NASDAQ: CGIX) A registration statement was recently filed with the SEC regarding StemoniX&#8217;s acquisition of Cancer Genetics.\u00a0 Under the proposed transaction, Cancer Genetics shareholders will control 22% of the combined company.\u00a0 The investigation concerns whether Cancer Genetics&#8217;s board oversaw an unfair process and ultimately agreed to an inadequate price. Akers Biosciences, Inc. ( NASDAQ: AKER ) Akers &hellip; Continue reading \"Moore Kuehn Encourages CGIX, AKER, TGC and DNKN Investors to Contact Law Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-17T17:13:20+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/698123\/Moore_Kuehn_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Moore Kuehn Encourages CGIX, AKER, TGC and DNKN Investors to Contact Law Firm","datePublished":"2020-11-17T17:13:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\/"},"wordCount":407,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/698123\/Moore_Kuehn_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\/","name":"Moore Kuehn Encourages CGIX, AKER, TGC and DNKN Investors to Contact Law Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/698123\/Moore_Kuehn_Logo.jpg","datePublished":"2020-11-17T17:13:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/698123\/Moore_Kuehn_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/698123\/Moore_Kuehn_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moore-kuehn-encourages-cgix-aker-tgc-and-dnkn-investors-to-contact-law-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Moore Kuehn Encourages CGIX, AKER, TGC and DNKN Investors to Contact Law Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/383281","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=383281"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/383281\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=383281"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=383281"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=383281"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}